Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 03:40PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.47 Insider Own1.75% Shs Outstand98.56M Perf Week2.13%
Market Cap53.87M Forward P/E- EPS next Y-0.19 Insider Trans0.00% Shs Float96.84M Perf Month68.18%
Income-41.05M PEG- EPS next Q-0.09 Inst Own6.70% Short Float0.52% Perf Quarter56.17%
Sales1.00M P/S53.87 EPS this Y-0.54% Inst Trans1.51% Short Ratio0.74 Perf Half Y-23.00%
Book/sh-0.02 P/B- EPS next Y50.00% ROA-108.83% Short Interest0.50M Perf Year-48.92%
Cash/sh0.14 P/C3.88 EPS next 5Y- ROE-341.28% 52W Range0.27 - 1.15 Perf YTD76.89%
Dividend Est.- P/FCF- EPS past 5Y36.56% ROI- 52W High-52.47% Beta1.21
Dividend TTM- Quick Ratio0.85 Sales past 5Y0.00% Gross Margin97.28% 52W Low102.44% ATR (14)0.05
Dividend Ex-Date- Current Ratio0.85 EPS Y/Y TTM-62.76% Oper. Margin-4189.90% RSI (14)66.60 Volatility22.46% 11.45%
Employees30 Debt/Eq- Sales Y/Y TTM-90.00% Profit Margin-4104.71% Recom1.40 Target Price4.50
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-10.14% Payout- Rel Volume0.85 Prev Close0.57
Sales Surprise36.37% EPS Surprise7.04% Sales Q/Q- EarningsNov 09 BMO Avg Volume678.92K Price0.55
SMA2039.01% SMA5052.95% SMA200-4.51% Trades Volume547,714 Change-4.77%
Feb-22-24 08:00AM
Jan-31-24 08:00AM
Jan-26-24 04:30PM
Jan-17-24 08:00AM
Jan-04-24 08:00AM
08:00AM Loading…
Dec-26-23 08:00AM
Dec-20-23 08:00AM
Dec-13-23 08:00AM
Dec-07-23 08:00AM
Dec-04-23 08:00AM
Nov-23-23 03:38PM
Nov-20-23 08:00AM
Nov-13-23 08:00AM
Nov-10-23 10:16AM
Nov-09-23 08:00AM
08:00AM Loading…
Nov-06-23 08:00AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
Oct-16-23 08:00AM
Sep-21-23 08:00AM
Sep-20-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:00AM
Aug-30-23 08:00AM
Aug-12-23 09:35AM
Aug-10-23 09:30AM
Aug-09-23 08:00AM
Aug-03-23 08:00AM
Jul-31-23 08:00AM
08:53AM Loading…
Jul-29-23 08:53AM
Jul-11-23 05:30PM
Jul-06-23 08:00AM
Jul-05-23 08:00AM
Jun-21-23 08:00AM
Jun-18-23 09:55AM
Jun-14-23 08:00AM
Jun-09-23 08:00AM
Jun-05-23 08:00AM
Jun-01-23 08:00AM
May-31-23 08:00AM
May-16-23 12:06PM
May-11-23 09:25AM
May-04-23 08:00AM
Apr-20-23 08:00AM
Apr-19-23 08:00AM
Apr-18-23 08:00AM
Apr-17-23 08:00AM
Mar-30-23 08:00AM
Mar-23-23 08:00AM
Mar-01-23 08:00AM
Feb-22-23 08:00AM
Feb-01-23 08:00AM
Jan-26-23 08:00AM
Jan-21-23 07:16AM
Jan-09-23 12:00PM
Dec-12-22 08:00AM
Dec-11-22 09:58AM
Nov-15-22 12:00PM
Nov-14-22 08:00AM
Nov-10-22 07:05AM
Nov-08-22 08:00AM
Nov-03-22 08:00AM
Nov-01-22 08:00AM
Oct-17-22 08:00AM
Oct-10-22 08:00AM
Sep-15-22 08:00AM
Sep-06-22 08:00AM
Aug-29-22 08:00AM
Aug-24-22 08:00AM
Aug-12-22 06:53AM
Aug-09-22 08:00AM
Aug-02-22 08:00AM
Jul-07-22 08:00AM
Jul-04-22 10:14AM
Jun-30-22 08:00AM
Jun-27-22 02:40PM
Jun-24-22 08:00AM
Jun-06-22 08:00AM
May-16-22 08:00AM
May-12-22 07:15AM
May-11-22 08:00AM
May-05-22 08:00AM
Apr-14-22 08:00AM
Apr-12-22 08:00AM
Apr-06-22 10:07AM
Dare Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.